Why Should You Put Apellis Pharmaceuticals Inc (NASDAQ: APLS) On Your Portfolio?
Currently, there are 119.56M common shares owned by the public and among those 100.98M shares have been available to trade. The company’s stock has a 5-day price change of 4.46% and -18.66% over the past three months. APLS shares are trading -52.29% year to date (YTD), with the 12-month market performance down to -42.09% lower. […]
Apellis Pharmaceuticals Inc (NASDAQ: APLS) Loses -62.80% From High. Why That Could Change?
Currently, there are 119.56M common shares owned by the public and among those 100.98M shares have been available to trade. The company’s stock has a 5-day price change of -4.82% and -26.88% over the past three months. APLS shares are trading -54.14% year to date (YTD), with the 12-month market performance down to -30.75% lower. […]
Look At Analyst Expectations For A Better Read On Apellis Pharmaceuticals Inc (NASDAQ: APLS)
Currently, there are 119.56M common shares owned by the public and among those 101.06M shares have been available to trade. The company’s stock has a 5-day price change of -9.79% and -20.70% over the past three months. APLS shares are trading -53.66% year to date (YTD), with the 12-month market performance down to -27.08% lower. […]
Are Analysts Expecting A Better 2020 For Apellis Pharmaceuticals Inc (APLS)?
Apellis Pharmaceuticals Inc (APLS) concluded trading on Thursday at a closing price of $68.12, with 2.62 million shares of worth about $178.14 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 181.84% during that period and on Thursday the price saw a gain of […]
Growth Story Still Intact For Apellis Pharmaceuticals Inc (APLS)
Wellington Management Co. LLP has recently announced that it has increased stake in Apellis Pharmaceuticals Inc (NASDAQ:APLS) by 127.59%. After grabbing 15.17 million shares, the institutional investor is now in possession of 8.5 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 12.80% having worth around $738.03 million. […]
